help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oda, Y.
Right arrow Articles by Rees Smith, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oda, Y.
Right arrow Articles by Rees Smith, B.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Clinical Endocrinology & Metabolism Vol. 84, No. 6 2119-2125
Copyright © 1999 by The Endocrine Society


Original Studies

Analysis of Carbohydrate Residues on Recombinant Human Thyrotropin Receptor

Yasuo Oda1, Jane Sanders, Sara Roberts, Masayuki Maruyama1, Angela Kiddie, Jadwiga Furmaniak and Bernard Rees Smith

FIRS Laboratories, RSR Ltd. (Y.O., J.S., S.R., M.M., A.K., J.F., B.R.S.), Parc-Ty-Glas, Llanishen, Cardiff, United Kingdom CF4 5DU; and the Department of Medicine, University of Wales College of Medicine (Y.O., S.R., M.M., J.F., B.R.S.), Heath Park, Cardiff, United Kingdom CF4 4XN

Address all correspondence and requests for reprints to: Dr. B. Rees Smith, FIRS Laboratories, RSR Ltd., Parc Ty Glas, Llanishen, Cardiff, United Kingdom CF4 5DU.


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
An investigation of the sugar groups on recombinant human TSH receptors (TSHR) expressed in CHO-K1 cells and solubilized with detergents is described. Western blotting studies with TSHR monoclonal antibodies showed that the receptor was present principally as two bands with approximate molecular masses of 120 and 100 kDa. Further blotting studies using lectins and/or involving treatment with different glycosidases indicated that the 100-kDa band contained about 16 kDa of high mannose-type sugars, and the 120-kDa band contained about 33 kDa of complex-type sugars. It was possible to separate the 120- and 100-kDa components of the TSHRs by lectin affinity chromatography. In particular, Galanthus nivalis lectin, which binds high mannose-type sugars, bound the 100-kDa band, but not the 120-kDa band, whereas Datura stramonium lectin, which binds complex-type sugars, bound the 120-kDa band, but not the 100-kDa band. 125I-Labeled TSH binding studies with the various lectin column fractions showed that TSH-binding activity was principally associated with the complex-type sugar containing the 120-kDa form of the receptor rather than the high mannose-containing 100-kDa form.

During peptide chain glycosylation, high mannose-type sugar residues are attached first and then modified by the formation of complex type structures to form the mature glycoprotein. Our data suggest that in the case of the TSH receptor, this type of posttranslational processing has an important role in forming the TSH-binding site.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
THE TSH receptor (TSHR) is a key protein in the control of thyroid function and is a major autoantigen in Graves’ disease (1). The TSHR belongs to a subgroup of G protein-coupled receptors comprising the TSHR, the FSH receptor, and the LH/CG receptor. These three G protein-coupled receptors are characterized by large, heavily glycosylated extracellular domains (ECD) that form the hormone-binding sites (1).

The human TSHR consists of a polypeptide chain of 764 amino acids with a calculated molecular mass of 84 kDa (2, 3, 4, 5, 6). The part of the ECD between amino acids 317 and 366 is particularly susceptible to proteolysis, and cleavage of the receptor in this region gives rise to a two-subunit structure in which the ECD (A subunit) and transmembrane domain (B subunit) are linked only by a disulfide bridge(s) (1, 7, 8).

When the human TSHR is expressed in CHO-K1 cells, Western blotting shows the receptor running as a 100-kDa/120-kDa doublet (1, 7, 8, 9, 10), and we now describe a study of sugar residues in these two forms of the receptor. In particular, the extent of glycosylation and types of sugar residues involved have been investigated using glycosidases and lectins. Furthermore, the relationship between TSHR glycosylation and TSH binding was studied after separation of the 100- and 120-kDa TSHR species using lectin affinity chromatography.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Production of antibodies

Six- to 8-week-old BALB/c mice were immunized with 50 µg glutathione-S-transferase-TSHR fusion proteins, and monoclonal antibodies were produced as described previously (10).

Preparation of detergent-solubilized recombinant human TSHR

Production of a eukaryotic cell line (CHO-K1) expressing the full-length TSHR (4 x 105 functional receptors/cell, as assessed by Scatchard analysis of TSH binding) was as previously described (10, 11). CHO-K1 cells were grown to confluence for 4 days in 175-cm2 flasks, and the cells were washed with Dulbecco’s phosphate-buffered saline without calcium and magnesium ions (Life Technologies) and scraped into 10 mL ice-cold 50 mmol/L NaCl and 10 mmol/L Tris-HCl, pH 7.5, containing 1 mmol/L phenylmethylsulfonylfluoride (buffer A). The cells were centrifuged at 1,000 x g for 5 min at 4 C, the pellet was resuspended in 1 mL buffer A and homogenized with a glass homogenizer on ice. This homogenate was then centrifuged at 12,000 x g for 30 min at 4 C, resuspended in 1 mL ice-cold buffer A containing 1% Triton X-100, homogenized, and centrifuged at 90,000 x g for 2 h at 4 C, and the supernatant was aliquoted and stored at -70 C. Scatchard analysis indicated that the solubilized preparations contained 2.4 µg TSHR/mL (11). Solubilized preparations contained 1.8 µg TSHR/mg total protein as assessed by the method of Bradford (12) (reagents from Bio-Rad Laboratories, Inc., Hemel Hempstead, UK).

Affinity purification of recombinant human TSHR

TSHR antibody IgGs were purified from ascitic fluid using affinity chromotography on Prosep A (Bioprocessing, Consett, UK) according to the manufacturer’s instructions. Twenty milligrams of purified 3F3 IgG (10) were coupled to 1 g cyanogen bromide-activated Sepharose 4B (Pharmacia Biotech, St. Albans, UK) according to the manufacturer’s instructions. Solubilized TSHR was loaded onto the affinity column in 150 mmol/L Tris-HCl (pH 8.3), 50 mmol/L NaCl, and 1% Triton X-100; eluted with 0.1 mol/L glycine/NaOH (pH 11), 500 mmol/L NaCl, and 0.1% Triton X-100; and dialyzed against 10 mmol/L Tris-HCl (pH 7.5), 50 mmol/L NaCl, and 0.1% Triton X-100. The peak fractions were pooled and stored in aliquots at -70 C for deglycosylation and lectin studies. The concentration of TSHR in these preparations was about 300 µg/mg protein (as assessed from Coomassie blue-stained SDS-polyacrylamide gels and Bradford assay).

Deglycosylation of TSHRs and SDS-PAGE followed by Western blotting

Endoglycosidase H (Endo H), N-glycosidase F (PNGase F), and neuraminidase were obtained from Boehringer Mannheim (Lewes, UK). Twenty-five microliters of either solubilized (~60 ng) or affinity-purified (~500 ng) TSHR were incubated for 16 h at room temperature in the enzyme buffer, with or without enzyme. Deglycosylation reactions were carried out according to the manufacturer’s instructions using Endo H (1 mU/reaction) in 50 µL 25 mmol/L sodium acetate (pH 5.5), PNGase F (1 mU/reaction) in 50 µL 50 mmol/L sodium phosphate (pH 6.0), 25 mmol/L ethylenediamine tetraacetate, 0.05% SDS, 0.5% ß-mercaptoethanol, 0.5% Triton-X-100, and neuraminidase (200 mU/reaction) in 50 µL 50 mmol/L sodium acetate (pH 5.5) containing 2 mmol/L CaCl2. After incubation, the samples were mixed with an equal volume of SDS-PAGE sample buffer [4% SDS, 20% glycerol, 100 mmol/L Tris-HCl (pH 6.8), and 0.002% bromophenol blue] plus dithiothreitol (10 mmol/L), heated to 100 C for 3 min, electrophoresed on 9% acrylamide gels (SDS-PAGE) (13), and blotted onto nitrocellulose (Schleicher & Schuell, Inc., UK Ltd., London, UK). Western blotting analysis was carried out according to the method of Birk and Koepsell (14). The membranes were blocked using 1 mg/mL polyvinyl alcohol in phosphate-buffered saline (Sigma Chemical Co., Poole, UK) and developed using antimouse horseradish peroxidase conjugate followed by enhanced chemiluminescence reagents (Amersham, Little Chalfont, UK).

Lectin analysis

The biotin-labeled lectins Aleuria aurantia (AAL), Canavalia ensiformis (Con A), Dolichos biflorus (DBA), Datura stramonium (DSL), Griffonia simplicifolia (GSL), Galanthus nivalis (GNL), Lotus tetragonobus (LTL), Lycopersion esculentum (LEL), Maackia amurensis (MALII), Samuccus nigra (SNA), Solanum tuberosum (STL), and wheat-germ agglutinin (WGA) were purchased from Vector Laboratories, Inc. (Peterborough, UK; Table 1Go).


View this table:
[in this window]
[in a new window]
 
Table 1. Reactivity of the recombinant human TSHR doublet with lectins of different specificity

 
Twenty-five-microliter samples of affinity-purified TSHR were mixed with an equal volume of SDS-PAGE sample buffer plus dithiothreitol (10 mmol/L) and heated to 100 C for 3 min, electrophoresed on 9% SDS-PAGE gels, and blotted onto nitrocellulose membranes. The membranes were then washed in TBST [50 mmol/L Tris-HCl (pH 7.5), 150 mmol/L NaCl, and 0.05% Tween-20], blocked overnight at 25 C in 3% gelatin in TBST with gentle shaking, and washed three times in TBST. After this washing step, the membranes were incubated for 150 min with 10 µg/mL biotin-labeled lectin in TBST, 1% gelatin, and 0.1 mmol/L CaCl2 or 0.1 mmol/L MnCl2 (according to the manufacturer’s instructions) and washed in TBST. Incubation with a 1:2000 dilution of streptavidin-horseradish peroxidase conjugate (Vector Laboratories, Inc.) in TBST was then carried out for 150 min, and the reaction was developed with horseradish peroxidase color development reagent (Bio-Rad Laboratories, Inc.) according to the manufacturer’s instructions.

In some experiments, digoxigenin-labeled lectins GNL, MALII, Samuccus nigra, and DSL were used according to the manufacturer’s instructions and developed using the DIG Glycan Differentiation Kit (Boehringer Mannheim; Table 1Go).

GNL affinity chromatography

3F3 affinity-purified receptor (2 mL) was loaded on a 1-mL column of agarose-bound GNL (Vector Laboratories, Inc.) in binding buffer [150 mmol/L Tris-HCl (pH 8.3), 50 mmol/L NaCl, and 0.1% Triton X-100], eluted with 0.1 mol/L {alpha}-methyl-D-mannoside (Sigma Chemical Co.) in binding buffer, and dialyzed against 10 mmol/L Tris-HCl (pH 7.5), 50 mmol/L NaCl, and 0.1% Triton X-100. The load material, wash fractions, and eluted fractions were tested for TSH binding (see below for method) and were analyzed by SDS-PAGE on 9% polyacrylamide gels followed by Western blotting.

DSL affinity chromatography

3F3 affinity-purified receptor (2 mL) was loaded onto a 1-mL column of agarose-bound DSL (Vector Laboratories, Inc.) in binding buffer 2 [10 mmol/L Tris-HCl (pH 7.5), 50 mmol/L NaCl, and 0.1% Triton X-100], eluted with 20% chitin hydrolysate (Vector Laboratories, Inc.) in binding buffer 2, and dialyzed against this buffer. The load material, wash fractions, and eluted fractions were then analyzed as described for the GNL affinity chromatography studies.

TSH binding assays

TSH binding assays were carried out on duplicate 50-µL aliquots of 1:8 diluted column fractions that were incubated with 50 µL [125I]TSH [15,000 cpm diluted in 10 mmol/L Tris-HCl (pH 7.4), 50 mmol/L NaCl, 1 g/L BSA, and 3 mmol/L NaN3] at 37 C for 1 h. TSHR-[125I]TSH complexes were precipitated by the addition of 2 mL 16% (wt/vol) polyethylene glycol 4000 (RSR Ltd., Cardiff, UK) and 25 µL normal pool serum as coprecipitant, followed by centrifugation (1,500 x g for 30 min at 4 C), and the precipitates were counted in a {gamma}-counter.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Deglycosylation of the TSHR

Western blotting analysis of affinity-purified recombinant human TSHR preparations treated with glycosidases, Endo H, PNGase F, and neuraminidase is shown in Fig. 1Go.



View larger version (48K):
[in this window]
[in a new window]
 
Figure 1. Deglycosylation of recombinant human TSHR; analysis by Western blotting. Panel 1, Effects of Endo H. Panel 2, Effects of PNGase F. Panel 3, Effects of neuraminidase. Panel 4, Untreated receptor. +, Reaction mixture incubated in the presence of glycosidase. -, Reaction mixture incubated under the same conditions in the absence of glycosidase (i.e. incubation with the reaction buffers only). See text for experimental details. Blots were reacted with TSHR monoclonal antibody 3C7 (ascites, 1:100 dilution in TBST). Results shown are typical of five separate experiments carried out with each of the three glycosidases. Differences in the intensity of the untreated TSHR bands (panel 4) compared to TSHR treated with glycosidases buffers (panels 1–3) are most likely related to the effect of prolonged incubation with the glycosidase buffers (see Materials and Methods for details of these buffers and incubation conditions).

 
The untreated TSHR preparation (Fig. 1Go, panel 4) was present as two bands of 117.0 ± 4.0 kDa (defined as the 120-kDa band) and 99.0 ± 4.0 kDa (defined as the 100-kDa band; mean ± SD; n = 5). These 120- and 100-kDa bands are referred to subsequently as the upper and lower (respectively) full-length TSHR bands. After treatment with Endo H (Fig. 1Go, panel 1, lane +), TSHR was visible as two full-length bands of 117.4 ± 4.2 and 83.3 ± 2.8 kDa (mean ± SD; n = 5), whereas TSHR treated with buffer only (Fig. 1Go, panel 1, lane -) was present as two bands of 117.4 ± 4.2 and 99.4 ± 3.6 kDa (mean ± SD; n = 5). These experiments showed that treatment with Endo H resulted in a change in mobility of the lower TSHR band of 16 ± 1.9 kDa (mean ± SD; n = 5). The mobility of the upper band of the TSHR doublet was essentially unchanged.

TSHR preparations treated with PNGase F (Fig. 1Go, panel 2, lane +) were visible as a broad band of 88.0 ± 5kDa (mean ± SD; n = 5), whereas TSHR treated with buffer only (Fig. 1Go, panel 2, lane -) was present as a doublet of 117.4 ± 4.2 and 99.4 ± 3.6 kDa (mean ± SD; n = 5). Treatment with PNGase F resulted in a change in mobility of 29.2 ± 3 kDa (mean ± SD; n = 5) for the upper TSHR band and 11.2 ± 2.7 kDa (mean ± SD; n = 5) for the lower TSHR band.

TSHR treated with neuraminidase (Fig. 1Go, panel 3, lane +) was present as two bands of 108.5 ± 3.3 and 99.7 ± 3.2 kDa (mean ± SD; n = 5), whereas TSHR incubated with buffer only (Fig. 1Go, panel 3, lane -) was present as a doublet of 117.9 ± 3.6 and 99.7 ± 3.2 kDa (mean ± SD; n = 5). After treatment with neuraminidase, the mobility of the upper band of the TSHR doublet was decreased by 9.4 ± 1.4 kDa (mean ± SD; n = 5), whereas the mobility of the lower band was essentially unchanged.

Lectin blotting analysis

The ability of affinity-purified recombinant human TSHR preparations to bind different lectins was investigated using lectin blotting analysis. The reactivity of TSHR with Con A, DSL, and MALII is shown in Fig. 2Go. Con A (lane 1) reacted strongly with the lower TSHR band of 95 ± 4 kDa (mean ± SD; n = 4) and weakly with the upper 114 ± 6-kDa (mean ± SD; n = 4) TSHR band. In contrast, DSL and MALII both reacted only with the upper band of the TSHR doublet, at 115 ± 7 kDa (mean ± SD; n = 7) and 116 ± 2 kDa (mean ± SD; n = 3), respectively. Neither DSL nor MALII appeared to react with the lower band of the TSHR doublet. The reactivity of different lectins with the two full-length TSHR bands is summarized in Table 1Go.



View larger version (88K):
[in this window]
[in a new window]
 
Figure 2. Lectin blotting analysis of recombinant human TSHR. Lane 1, Reactivity with Con A. Lane 2, Reactivity with DSL. Lane 3, Reactivity with MALII. See text for experimental details. Results shown are typical of four, seven, and three separate experiments in the cases of Con A, DSL, and MALII, respectively.

 
To extend these deglycosylation and lectin studies, we tested the reactivity of DSL with the upper TSHR band before and after treatment with glycosidases (Fig. 3Go). In this experiment, DSL reaction with the untreated TSHR was evident as a band at 119 ± 1 kDa (mean ± SD; n = 3; Fig. 3Go, panel 1). After treatment with Endo H (Fig. 3Go, panel 2), no shift in molecular mass was observed. However, after incubation of the TSHR with neuraminidase, the 119-kDa band reactive with DSL was shifted to 107 ± 2 kDa (mean ± SD; n = 3), a shift of approximately 12 kDa (Fig. 3Go, panel 3). In the case of PNGase F (Fig. 3Go, panel 4), DSL did not react with the TSHR after treatment of the receptor with this enzyme.



View larger version (69K):
[in this window]
[in a new window]
 
Figure 3. Analysis of recombinant human TSHR after treatment with different glycosidases by lectin blotting with DSL. Panel 1, Untreated TSHR. Panel 2, TSHR treated with Endo H (+) and TSHR incubated under the same conditions in the absence of Endo H (-). Panel 3, TSHR treated with neuraminidase (+) and TSHR incubated under the same conditions in the absence of neuraminidase (-). Panel 4, TSHR treated with PNGase F (+) and TSHR incubated under the same conditions in the absence of PNGase F (-). See text for experimental details. Results shown are typical of three separate experiments with each glycosidase.

 
GNL lectin affinity chromatography

To separate the two bands forming the TSHR doublet, we used lectin affinity chromatography. In these experiments, GNL affinity column fractions were reacted with 3C6 TSHR monoclonal antibody (ascites fluid diluted 1:100) (10) in Western blotting (Fig. 4Go). The unfractionated load material was present as two full-length TSHR bands at 115.0 ± 2.5 and 98.0 ± 0.8 kDa (mean ± SD; n = 4) and some TSHR A subunit at 51.0 ± 1.0 kDa (mean ± SD; n = 4). The amounts of A subunit in different TSHR preparations showed some variations, but the major components observed were the two full-length receptor bands. The unretarded column fractions (Fig. 4Go, lanes W1–W8) contained the upper TSHR band and the receptor A subunit, whereas the eluted fractions (Fig. 4Go, lanes E4–E9) contained the lower band. TSH binding assays were carried out in three of the four experiments on the unfractionated load material, the unretarded column fractions, and the eluted fractions. An example of TSH binding to GNL column fractions is shown in Fig. 5Go. The TSH-binding activity in the unretarded column fractions represented 82 ± 17% (mean ± SD; n = 3) of the TSH-binding activity loaded onto the column (Table 2Go).



View larger version (48K):
[in this window]
[in a new window]
 
Figure 4. GNL lectin affinity chromatography of recombinant human TSHR; analysis by Western blotting. L, Load material. W1–W8, Unretarded (wash) fractions from the GNL column. E4–E9, Fractions eluted from the GNL column with 0.1 mol/L {alpha}-methyl-D-mannoside. See text for experimental details. Results shown are typical of four separate experiments.

 


View larger version (13K):
[in this window]
[in a new window]
 
Figure 5. Analysis of [125I]TSH-binding activity by different fractions of recombinant human TSHRs separated by lectin affinity chromatography. •, Material from GNL affinity chromatography. {blacktriangleup}, Material from DSL affinity chromatography. W2–W9, Unretarded (wash) fractions. E4–E12, Fractions eluted with sugar. % TSH bound = mean of % 125I-labeled TSH bound to duplicate 50-µL aliquots of each column fraction (diluted 1:8) minus % 125I-labeled TSH bound in the presence of 50 µL buffer only (nonspecific binding). See text for full experimental details. Results shown are typical of three separate experiments (see also Table 2Go). The affinities of the TSHR preparations not retarded by the GNL column or not retarded by the DSL column were similar (1010 mol/L-1) as assessed by Scatchard analysis (11 ) of TSH binding.

 

View this table:
[in this window]
[in a new window]
 
Table 2. Lectin affinity chromatography of TSHR; summary of [125I]TSH binding by GNL and DSL column fractions

 
DSL affinity column

The results obtained with DSL affinity chromatography were opposite those obtained with GNL, as shown in Fig. 6Go. Unfractionated load material contained two full-length TSHR bands of 113.0 ± 4.0 and 98.5 ± 1.0 kDa (mean ± SD; n = 5) and a lower molecular mass band of 50.8 ± 0.4 kDa (mean ± SD; n = 5) corresponding to the receptor A subunit. The unretarded column fractions (Fig. 6Go, lanes W3–W8) contained the lower band (98.5 kDa) of the TSHR doublet, whereas the eluted fractions (Fig. 6Go, lanes E4–E10) contained mainly the upper band of the doublet and the 50-kDa A subunit. Small amounts of the lower 98-kDa band were also observed in the eluted fractions. TSH binding assays were carried out in three of the five experiments on the unfractionated load material, the unretarded column fractions, and the eluted fractions. An example of TSH binding by the unretarded column fractions and the eluted fractions for one DSL column is shown in Fig. 5Go. The TSH-binding activity in the unretarded column fractions represented 29 ± 1.2% (mean ± SD; n = 3) of the TSH-binding activity loaded onto the column (Table 2Go). The TSH-binding activity in the unretarded column fractions of the GNL column was different from that of the DSL column, as determined using unpaired t test with Welch’s correction (P < 0.01).



View larger version (55K):
[in this window]
[in a new window]
 
Figure 6. DSL lectin affinity chromatography of recombinant human TSHR; analysis by Western blotting. L, Load material. W3–W8, Unretarded (wash) fractions from DSL column. E4–E10, Fractions eluted from DSL column with 20% chitin hydrolysate. See text for experimental details. Results shown are typical of five separate experiments. The apparent higher concentration of the band representing the TSHR A subunit in the eluted fractions (E7–E9) compared to load material (L) may reflect relatively stronger binding of the A subunit to the DSL column.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
In the current report, Western blotting of untreated recombinant human TSHR showed the TSHR to be present as its characteristic doublet. The molecular mass of the lower band was between 95–100 kDa in the many experiments we describe, and this material is referred to as the 100-kDa band. The higher molecular mass band ran between 113–119 kDa, and this material is referred to as the 120-kDa band. The molecular mass values obtained for the 120-kDa band were less precise than those for the 100-kDa band due mainly to the poorer resolving power of the gels at the higher molecular mass, but the results are in good agreement with previous studies (1, 7, 8, 9, 10). The calculated peptide chain molecular weight of the TSHR is only 84 kDa (2, 3, 4, 5, 6), and previous reports indicate that glycosylation of the TSHR peptide chain is principally responsible for the higher molecular masses observed on Western blotting (9, 15). In our studies, treatment of the receptor with PNGase F, which removes high mannose and complex type N-linked sugar residues (16), caused the TSHR doublet to run essentially as a single band of approximately 84 kDa, corresponding to the expected molecular mass of the TSHR polypeptide chain. These observations indicated that extensive carbohydrate residues were associated with both bands of the TSHR doublet.

Our results show that sugar residues contribute approximately 33 kDa to the overall molecular mass of the TSHR upper band and approximately 16 kDa to the overall molecular mass of the TSHR lower band, as judged by mobility on SDS-PAGE. Furthermore, our studies indicate that the lower TSHR band contains predominantly high mannose-type sugars whereas the upper TSHR band contains mostly complex-type sugars. These results are in agreement with reports from other laboratories using pulse labeling of CHO-K1 cells and L cells (9). In addition, pulse labeling experiments in stably transfected L cells suggested that the lower recombinant TSHR band was the precursor for the upper, fully glycosylated TSHR band (9). This is consistent with the general understanding that during the glycosylation process high mannose-type sugar residues are first attached to glycosylation sites on the peptide chain, and these residues are then modified to form complex-type structures that give rise to final "matured" glycosylated protein (17). Consequently, our studies together with results from other laboratories suggest that the 100-kDa band of the TSHR doublet represents the high mannose precursor, whereas the 120-kDa band represents the mature, fully glycosylated TSHR (15).

A more detailed analysis of the carbohydrate residues present in the two bands of the TSHR doublet was carried out using lectin blotting analysis. The lower band of the TSHR was found to react with Con A, which is specific for {alpha}-linked mannose (18) and also reacted with GNL, which recognizes {alpha}(1, 2, 3)-linked mannose residues (19). This was not unexpected, as a wide variety of membrane glycoproteins contain a core oligosaccharide structure of {alpha}-linked mannose (17). The upper band of the TSHR doublet reacted with Aleuria aurantia, indicating the presence of either fucose-linked [{alpha}(1, 2, 3, 4, 5, 6)] N-acetylglucosamine or fucose-linked [{alpha}(1, 2, 3)] N-acetylactosamine (20), and with DSL, indicating the presence of ß(1, 2, 3, 4)-linked N-acetylglucosamine (21). In addition, the upper TSHR band reacted with both Lycopersion esculentum and wheat-germ agglutinin, indicating the presence of N-acetylglucosamine (22, 23) and with MALII, which is known to bind to carbohydrate structures containing {alpha}(2, 3)-linked sialic acid (24). A weak reaction with the upper TSHR band was also observed with Con A, probably due to a low affinity reaction between this lectin and N-acetylglucosamine (18). All of the sugar residues found to be associated with the upper TSHR band are complex-type sugar residues. Consequently, lectin blotting analyses confirmed that the lower band of the TSHR doublet contains high mannose-type carbohydrate, whereas the upper band contains complex-type carbohydrate.

These studies were extended by analysis of the reactivity of biotin-labeled DSL with the TSHR after treatment with different glycosidases. After Endo H treatment, reactivity of the upper band (running at 119 kDa) was unaffected, suggesting that no terminal mannose residues were present in this component of the TSHR doublet. However, after treatment with neuraminidase, DSL reacted with the digested upper TSHR band now running at a lower molecular mass of 107 kDa (showing a difference of approximately 12 kDa from the untreated upper band), confirming the presence of sialic acid containing complex-type carbohydrates. After digestion with PNGase F, the upper band of the TSHR doublet did not bind DSL, probably due to the removal of all sugar residues that were capable of binding to this lectin.

A selection of lectins of different specificities was also tested in blotting analysis with the receptor preparations, but did not show reactivity. This lack of reactivity with the TSHR doublet could be attributed to the absence of the appropriate sugar residues or their inaccessibility to lectin binding (17). Alternatively, the concentration of the TSHR on the Western blot might have been too low to detect binding of the lectins.

Using lectin affinity chromatography we were able to separate the 120- and 100-kDa components of the TSHR doublet. The upper TSHR band (containing complex carbohydrate) bound to the DSL affinity column, whereas the unretarded column fractions contained the lower molecular mass TSHR band (containing high mannose residues). The opposite effect was seen when a GNL affinity column was used, and with this lectin the upper TSHR band (containing complex carbohydrate) was found in the unretarded column fractions, whereas the high mannose-containing lower band was retained by the GNL column. [125I]TSH binding studies revealed that about 80% of the TSH binding activity loaded onto the GNL column was present in the unretarded fractions containing the upper 120-kDa TSHR band. In contrast, only 30% of the TSH-binding activity loaded onto the DSL column was present in the unretarded fractions containing the 100-kDa TSHR high mannose precursor.

The observation that not all of the TSH-binding activity of the TSHR preparations was retarded by the DSL column probably reflected the limitations of the column affinity and/or capacity. This suggestion is supported by Scatchard analysis, which indicated that the affinities of TSHR in the nonretarded fractions from both DSL and GNL columns were similar. The results with the two lectin columns suggest that the 120-kDa band is principally responsible for TSH binding. The inability to detect the 120-kDa band in the unretarded fractions of the DSL column (which showed a small amount of TSH-binding activity) probably reflected limitations in the sensitivity of the Western blotting analysis. Consequently, the acquisition of complex carbohydrate by the TSHR appears to be an important factor in enabling the TSHR to bind TSH. This can be compared with reports that N-linked carbohydrates on the FSH receptor are important for folding the receptor into a conformation allowing FSH binding (25). In contrast, acquisition of complex carbohydrate has not been found important for hormone binding in the case of the LH/CG receptor (26, 27).

Although the DSL affinity column bound the 120-kDa band of the TSHR, attempts to elute the bound receptor with sugars were not very successful. In particular, eluted material did not bind TSH well even though the 120-kDa band was clearly present. The loss of TSH-binding activity was due presumably to unfolding of the receptor during binding to and elution from the lectin column.

An important role for complex carbohydrates in the correct folding of the extracellular domain of the TSHR is consistent at least in part with the inability to demonstrate TSH binding to TSHR produced in expression systems other than mammalian cells. For example TSHR produced in E. coli is unglycosylated (28, 29), and TSHR produced in the baculovirus system is only partially glycosylated, containing mainly high mannose-type sugar residues (30, 31, 32) and neither of the receptors bound TSH with high affinity (29, 30, 31, 32, 33). Furthermore, [35S]TSHR produced in vitro in the transcription/translation reaction system is unglycosylated and does not bind TSH (34, 35). In addition, the importance of TSHR’s glycosylation for TSH binding has been indicated also in studies using TSHR preparations containing mutated asparagine sites (36) or TSHR fragments expressed in High Five insect cells (37).

Consequently, current studies indicate that formation of the TSH-binding site on the TSHR is dependent on complex posttranslational modifications of the peptide chain in which carbohydrate residues play an important role. In particular, acquisition of complex-type sugar residues by the TSHR appears to be an important requirement for the formation of the TSH-binding site.


    Acknowledgments
 
We are most grateful to Kathy Earlam for preparing the manuscript.


    Footnotes
 
1 Recipient of an RSR fellowship. Back

Received September 3, 1998.

Revised January 28, 1999.

Accepted March 8, 1999.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Sanders J, Oda Y, Roberts, S-A, Maruyama M, Furmaniak J, Rees Smith B. 1997 Understanding the thyrotropin receptor function-structure relationship. In: Davies TF, ed. Baillière’s clinical endocrinology and metabolism. London: Baillière Tindall; vol 11:451–479.
  2. Libert F, Lefort A, Gerard C, et al. 1989 Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies. Biochem Biophys Res Commun. 165:1250–1255.[CrossRef][Medline]
  3. Nagayama Y, Kaufman K D, Seto P, Rapoport B. 1989 Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor. Biochem Biophys Res Commun. 165:1184–1190.[CrossRef][Medline]
  4. Parmentier M, Libert F, Maenhaut C, et al. 1989 Molecular cloning of the thyrotropin receptor. Science. 246:1620–1622.[Abstract/Free Full Text]
  5. Frazier L, Robbins L, Stork P, Sprengel R, Segaloff D, Cone R. 1990 Isolation of TSH and LH/CG receptor cDNAs from human thyroid: regulation by tissue specific splicing. Mol Endocrinol. 4:1264–1276.[Abstract/Free Full Text]
  6. Misrahi M, Loosfelt H, Atger M, Sar S, Guiochon-Mantel A, Milgrom E. 1990 Cloning, sequencing and expression of human TSH receptor. Biochem Biophys Res Commun. 166:394–403.[CrossRef][Medline]
  7. Chazenbalk GD, Tanaka K, Nagayama Y, et al. 1997 Evidence that the thyrotropin receptor ectodomain contains not one, but two, cleavage sites. Endocrinology. 138:2893–2899.[Abstract/Free Full Text]
  8. Tanaka K, Chazenbalk GD, McLachlan SM, Rapoport B. 1998 Thyrotropin receptor cleavage at site 1 does not involve a specific amino acid motif but instead depends on the presence of the unique, 50 amino acid insertion. J Biol Chem. 273:1959–1963.[Abstract/Free Full Text]
  9. Misrahi M, Ghinea N, Sar S, et al. 1994 Processing of the precursors of the human thyroid stimulating hormone receptor in various eukaryotic cells (human thyrocytes, transfected L cells and baculovirus infected insect cells). Eur J Biochem. 222:711–719.[Medline]
  10. Oda Y, Sanders J, Roberts S, et al. 1998 Binding characteristics of antibodies to the TSH receptor. J Mol Endocrinol. 20:233–244.[Abstract]
  11. Scatchard G. 1949 The attraction of proteins for small molecules and ions. Ann NY Acad Sci. 51:660–672.[CrossRef]
  12. Bradford MM. 1976 Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248–254.[CrossRef][Medline]
  13. Laemmli UK. 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680–684.[CrossRef][Medline]
  14. Birk H, Koepsell H. 1987 Reaction of monoclonal antibodies with plasma membrane proteins after binding on nitrocellulose: renaturation of antigenic sites and reduction of non-specific antibody binding. Anal Biochem. 164:12–22.[CrossRef][Medline]
  15. Rapoport B, McLachlan SM, Kakinuma A, Chazenbalk GD. 1996 Critical relationship between autoantibody recognition and thyrotropin receptor maturation as reflected in the acquisition of complex carbohydrate. J Clin Endocrinol Metab. 81:2525–2533.[Abstract]
  16. Tarentino AL, Gomez CM, Plummer TH Jr. 1985 Deglycosylation of asparagine-linked glycans by peptide: N-glycosidase F. Biochemistry. 24:4665–4671.[CrossRef][Medline]
  17. Delves PJ. 1998 The role of glycosylation in autoimmune disease. Autoimmunity. 27:239–253.[Medline]
  18. Freeze HH. 1997 Lectin affinity chromatography. In: Coligan JE, Dunn BM, Ploegh HL, Speicher DW, Wingfield PT, eds. Current protocols in protein science. New York: Wiley and Sons; 9.1.1.
  19. Shibuya N, Goldstein IJ, Van Damme EJM, Peumans WJ. 1988 Binding properties of a mannose specific lectin from the snowdrop (Galanthus nivalis) bulb. J Biol Chem. 263:728–734.[Abstract/Free Full Text]
  20. Goldstein IJ, Poretz RD. 1986 Isolation, physiochemical characterisation and carbohydrate binding specificy of lectins. In: Liener TF, Sharon N, Goldstein TJ, eds. The Lectin: Properties, Functions, and Applications in Biology and Medicine. New York: Academic Press; 34–243.
  21. Crowley J, Goldstein I, Arnarp J, Lonngren J. 1984 Carbohydrate binding studies on the lectin from Datura stramonium seeds. Arch Biochem Biophys. 231:524–533.[CrossRef][Medline]
  22. Nachbar MS, Oppenheim JD, Thomas, JO. 1980 Lectins in the US diet. Isolation and characterization of a lectin from the tomato (Lycopersicon esculentum). J Biol Chem. 255:2056–2061.[Free Full Text]
  23. Nagata Y, Burger MM. 1974 Wheat germ agglutinin. Molecular characteristics and specificity for sugar binding. J Biol Chem. 249:3116–3122.[Abstract/Free Full Text]
  24. Wang W, Cummings R. 1988 The immobilized leukoagglutinin from the seeds of Maackia amurensis binds with high affinity to complex type Asn linked oligosaccharides containing terminal sialic acid linked {alpha}-2,3 to penultimate galactose residues. J Biol Chem. 263:4576–4585.[Abstract/Free Full Text]
  25. Davies D, Liu X, Segaloff DL. 1995 Identification of the sites of N-linked glycosylation on the follocle-stimulating hormone (FSH) receptor and assessment of their role in FSH receptor function. Mol Endocrinol. 9:159–170.[Abstract/Free Full Text]
  26. Davies DP, RozellTG, Liu X, Segaloff DL. 1997 The six N-linked carbohydrates of the lutropin/choriogonadotropin receptor are not absolutely required for correct folding, cell surface expression, hormone binding, or signal transduction. Mol Endocrinol. 11:550–562.[Abstract/Free Full Text]
  27. Dufau ML. 1998 The luteinizing hormone receptor. Annu Rev Physiol. 60:461–496.[CrossRef][Medline]
  28. Harfst E, Johnstone, AP, Nussey SS. 1992 Characterization of the extracellular region of the human thyrotrophin receptor expressed as a recombinant protein. J Mol Endocrinol. 9:227–236.[Abstract/Free Full Text]
  29. Huang GC, Collison KS, McGregor AM, Banga JP. 1992 Expression of a human thyrotrophin receptor fragment in Escherichia coli and its interaction with the hormone and autoantibodies from patients with Graves’ disease. J Mol Endocrinol. 8:137–144.[Abstract/Free Full Text]
  30. Huang GC, Page MJ, Nicholson LB, Collison KS, McGregor AM, Banga JP. 1993 The thyrotrophin hormone receptor of Graves’ disease: overexpression of the extracellular domain in insect cells using recombinant baculovirus, immunoaffinity purification and analysis of autoantibody binding. J Mol Endocrinol. 10:127–142.[Abstract/Free Full Text]
  31. Seetharamaiah GS, Desai RK, Dallas JS, Tahara K, Kohn LD, Prabhakar BS. 1993 Induction of TSH binding inhibitory immunoglobulins with the extracellular domain of human thyrotropin receptor produced using baculovirus expression system. Autoimmunity. 14:315–320.[Medline]
  32. Seetharamaiah GS, Kurosky A, Desai RK, Dallas JS, Prabhakar BS. 1994 A recombinant extracellular domain of the thyrotropin (TSH) receptor binds TSH in the absence of membranes. Endocrinology. 134:549–554.[Abstract/Free Full Text]
  33. Harfst E, Nussey SS, Johnstone AP. 1992 Interaction of thyrotropin and thyroid stimulating antibodies with recombinant extracellular region of human TSH receptor. Lancet. 339:193–194.
  34. Morgenthaler NG, Tremble J, Huang G, Scherbaum WA, McGregor AM, Banga JP. 1996 Binding of antithyrotropin receptor autoantibodies in Graves’ disease serum to nascent, in vitro translated thyrotropin receptor: ability to map epitopes recognized by antibodies. J Clin Endocrinol Metab. 81:700–706.[Abstract]
  35. Prentice L, Sanders J, Perez M, et al. 1997 Thyrotropin (TSH) receptor autoantibodies do not appear to bind to the TSH receptor produced in an in vitro transcription/translation system. J Clin Endocrinol Metab. 82:1288–1292.[Abstract/Free Full Text]
  36. Russo D, Chazenbalk GD, Nagayama Y, Wadsworth HL, Rapoport B. 1991 Site-directed mutagenesis of the human thyrotropin receptor: role of asparagine-linked oligosaccharides in the expression of a functional receptor. Mol Endocrinol. 5:29–33.[Abstract/Free Full Text]
  37. Vlase H, Matsuoka N, Graves PN, Magnusson RP, Davies TF. 1997 Folding-dependent binding of thyrotropin (TSH) and TSH receptor autoantibodies to the murine TSH receptor ectodomain. Endocrinology. 138:1658–1666.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
R Nunez Miguel, J Sanders, D Y Chirgadze, T L Blundell, J Furmaniak, and B Rees Smith
FSH and TSH binding to their respective receptors: similarities, differences and implication for glycoprotein hormone specificity
J. Mol. Endocrinol., September 1, 2008; 41(3): 145 - 164.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
D. Calebiro, T. de Filippis, S. Lucchi, C. Covino, S. Panigone, P. Beck-Peccoz, D. Dunlap, and L. Persani
Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance
Hum. Mol. Genet., October 15, 2005; 14(20): 2991 - 3002.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Frenzel, K. Krohn, M. Eszlinger, A. Tonjes, and R. Paschke
Sialylation of Human Thyrotropin Receptor Improves and Prolongs Its Cell-Surface Expression
Mol. Pharmacol., October 1, 2005; 68(4): 1106 - 1113.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. Bell, A. Gagnon, L. Grunder, S. J. Parikh, T. J. Smith, and A. Sorisky
Functional TSH receptor in human abdominal preadipocytes and orbital fibroblasts
Am J Physiol Cell Physiol, August 1, 2000; 279(2): C335 - C340.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oda, Y.
Right arrow Articles by Rees Smith, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oda, Y.
Right arrow Articles by Rees Smith, B.
Right arrowPubmed/NCBI databases
*Substance via MeSH


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals